Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Anemia|April 15, 2011
Asthma in sickle cell disease: implications for treatmentKathryn Blake, John LimaExpert Opinion on Drug Metabolism & Toxicology|August 4, 2015
Pharmacogenomics of long-acting β2-agonistsKathryn Blake, John LimaChest|June 28, 2008
Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthmaKathryn Blake, Rajanikanth Madabushi, Hartmut Derendorf, et al.Pharmacogenetics and Genomics|February 14, 2009
5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist lociKelan G Tantisira, John Lima, Jody Sylvia, et al.Pulmonary Pharmacology & Therapeutics|February 7, 2013
Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16Kathryn Blake, James D Cury, Jobayer Hossain, et al.The Journal of Clinical Endocrinology and Metabolism|September 2, 2011
Pharmacokinetics and pharmacodynamics of oral and transdermal 17β estradiol in girls with Turner syndromeMartha Taboada, Richard Santen, John Lima, et al.The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
Pharmacokinetics and dose finding of a potent aromatase inhibitor, aromasin (exemestane), in young malesNelly Mauras, John Lima, Deval Patel, et al.Pharmacogenetics and Genomics|December 25, 2009
Development of a Pharmacogenetic Predictive Test in asthma: proof of conceptAnn Chen Wu, Blanca E Himes, Jessica Lasky-Su, et al.The Journal of Allergy and Clinical Immunology|February 2, 2011
The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthmaEmmanuelle M Clerisme-Beaty, Susan J Bartlett, W Gerald Teague, et al.The Journal of Allergy and Clinical Immunology|November 28, 2013
Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmaticsAnn Chen Wu, Blanca E Himes, Jessica Lasky-Su, et al.Pageof 1